Zining Jin
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Breast Cancer Treatment Studies
-
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in ⓘ
-
- Breast Cancer Treatment Studies 9
- Cancer-related molecular mechanisms research 5
-
- RNA Research and Splicing 4
- RNA modifications and cancer 3
- Co-authors
- Bo Chen (9 shared papers)Feng Jin (10 shared papers)Yuan Yuan (1 shared paper)Caiyun He (1 shared paper)Guanglei Chen (3 shared papers)Ang Zheng (7 shared papers)Miao He (2 shared papers)Min Zhao (3 shared papers)
- Journals
- Oncotarget (4 papers)OncoTargets and Therapy (2 papers)Frontiers in Oncology (2 papers)Molecular Carcinogenesis (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesSaint Kitts and Nevis
In The Last Decade
Zining Jin
26 papers receiving 301 citations
Peers
Comparison fields: 5 of 59
- Cancer Research 136
- Oncology 74
- Molecular Biology 186
- Pulmonary and Respiratory Medicine 61
- Pathology and Forensic Medicine 28
Countries citing papers authored by Zining Jin
This map shows the geographic impact of Zining Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zining Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zining Jin more than expected).
Fields of papers citing papers by Zining Jin
This network shows the impact of papers produced by Zining Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zining Jin. The network helps show where Zining Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Zining Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 63 | |
| 2 | 2019 | 28 | |
| 3 | 2016 | 27 | |
| 4 | 2017 | 22 | |
| 5 | 2020 | 21 | |
| 6 | 2015 | 21 | |
| 7 | 2020 | 17 | |
| 8 | 2015 | 15 | |
| 9 | 2020 | 14 | |
| 10 | Interleukin enhancer binding factor 2 is a prognostic biomarker for breast cancer that also predicts neoadjuvant chemotherapy responses. | 2018 | 12 |
| 11 | 2020 | 10 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 8 | |
| 14 | 2017 | 7 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2025 | 4 | |
| 18 | 2024 | 4 | |
| 19 | 2019 | 4 | |
| 20 | 2017 | 4 |
About Zining Jin
Zining Jin is a scholar working on Cancer Research, Molecular Biology, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 28 papers that have together received 309 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Breast Lesions and Carcinomas (6 papers), Cancer Cells and Metastasis (5 papers), Cancer-related molecular mechanisms research (5 papers), Ferroptosis and cancer prognosis (4 papers), RNA Research and Splicing (4 papers), Breast Implant and Reconstruction (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (136 citations), Oncology (74 citations), Molecular Biology (186 citations), Pulmonary and Respiratory Medicine (61 citations) and Pathology and Forensic Medicine (28 citations). Zining Jin has collaborated with scholars based in China, United States and Saint Kitts and Nevis. Frequent co-authors include Bo Chen, Feng Jin, Yuan Yuan, Caiyun He, Guanglei Chen, Ang Zheng, Miao He, Min Zhao, Zhan Li and Xuemei Lv. Their work appears in journals such as Oncotarget, OncoTargets and Therapy, Frontiers in Oncology, Molecular Carcinogenesis and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.